Your browser doesn't support javascript.
loading
Effective high-throughput RT-qPCR screening for SARS-CoV-2 infections in children
Felix Dewald; Isabelle Suarez; Ronja Johnen; Jan Grossbach; Roberto Tovar; Gertrud Steger; Alexander Joachim; Gibran Rubio; Mira Fries; Florian Behr; Joao Kley; Andreas Lingnau; Alina Kretschmer; Carina Gude; Guadelupe Flores; David del Valle; Alberto Hernandez; Jesus Cerino; Adriana Hernandez; Jesus Quinones; Konstantin Schega; Viktoria Linne; Lena Junker; Marie Wunsch; Eva Heger; Elena Knops; Veronica Di Cristanziano; Meike Meyer; Christoph Huenseler; Lutz T. Weber; Jan Lueers; Gustav Quade; Hilmar Wisplinghoff; Carsten Tiemann; Rainer Zotz; Hassan Jomaa; Arthur Pranada; Ileana Herzum; Paul Cullen; Franz Schmitz; Paul Philipsen; Georg Kirchner; Cornelius Knabbe; Martin Hellmich; Michael Buess; Anna Wolf; Annelene Kossow; Johannes Niessen; Sebastian Jeworutzki; Joerg Schraepler; Michael Laessig; Joerg Doetsch; Gerd Faetkenheuer; Rolf Kaiser; Andreas Beyer; Jan Rybniker; Florian Klein.
Afiliação
  • Felix Dewald; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  • Isabelle Suarez; Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany
  • Ronja Johnen; CECAD Research center, University of Cologne, Cologne, Germany
  • Jan Grossbach; CECAD Research center, University of Cologne, Cologne, Germany
  • Roberto Tovar; Institute for Biological Physics, University of Cologne, Cologne, Germany
  • Gertrud Steger; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  • Alexander Joachim; Department of Pediatrics, Childrens and Adolescents Hospital, University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany
  • Gibran Rubio; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  • Mira Fries; Health department of Cologne, Cologne, Germany
  • Florian Behr; Health department of Cologne, Cologne, Germany
  • Joao Kley; Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany
  • Andreas Lingnau; Ministry of Schools and Education of North Rhine-Westphalia, Duesseldorf, Germany
  • Alina Kretschmer; Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany
  • Carina Gude; CECAD Research center, University of Cologne, Cologne, Germany
  • Guadelupe Flores; Centro de Investigacion en Enfermedades Tropicales y Emergentes, Hospital Regional de Alta Especialidad, Dr. Juan Graham Casasus, Villahermosa, Mexico
  • David del Valle; Centro de Investigacion en Enfermedades Tropicales y Emergentes, Hospital Regional de Alta Especialidad, Dr. Juan Graham Casasus, Villahermosa, Mexico
  • Alberto Hernandez; Centro de Investigacion en Enfermedades Tropicales y Emergentes, Hospital Regional de Alta Especialidad, Dr. Juan Graham Casasus, Villahermosa, Mexico
  • Jesus Cerino; Centro de Investigacion en Enfermedades Tropicales y Emergentes, Hospital Regional de Alta Especialidad, Dr. Juan Graham Casasus, Villahermosa, Mexico
  • Adriana Hernandez; Bioclilab SA de CV, Villahermosa, Mexico
  • Jesus Quinones; Centro de Investigacion en Enfermedades Tropicales y Emergentes, Hospital Regional de Alta Especialidad, Dr. Juan Graham Casasus, Villahermosa, Mexico
  • Konstantin Schega; Health department of Cologne, Cologne, Germany
  • Viktoria Linne; Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany
  • Lena Junker; Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany
  • Marie Wunsch; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  • Eva Heger; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  • Elena Knops; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  • Veronica Di Cristanziano; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  • Meike Meyer; Department of Pediatrics, Childrens and Adolescents Hospital, University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany
  • Christoph Huenseler; Department of Pediatrics, Childrens and Adolescents Hospital, University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany
  • Lutz T. Weber; Department of Pediatrics, Childrens and Adolescents Hospital, University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany
  • Jan Lueers; Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne
  • Gustav Quade; MVZ Labor Dr. Quade und Kollegen GmbH, Cologne, Germany
  • Hilmar Wisplinghoff; Labor Dr. Wisplinghoff, Cologne, Germany
  • Carsten Tiemann; Labor Krone, Bad Salzuflen, Germany
  • Rainer Zotz; Labor ZotzKlimas, Duesseldorf, Germany
  • Hassan Jomaa; Synlab, Leverkusen, Germany
  • Arthur Pranada; Medizinisches Versorgungszentrum Dr. Eberhard und Partner, Dortmund, Germany
  • Ileana Herzum; Medizinische Laboratorien Duesseldorf, Duesseldorf, Germany
  • Paul Cullen; MVZ Labor Muenster, Muenster, Germany
  • Franz Schmitz; Muehlenkreiskliniken, Minden, Germany
  • Paul Philipsen; Labor Moenchengladbach MVZ Dr. Stein und Kollegen, Moenchengladbach, Germany
  • Georg Kirchner; Eurofins Laborbetriebsgesellschaft Gelsenkirchen GmbH und Eurofins MVZ Medizinisches Labor Gelsenkirchen GmbH, Gelsenkirchen, Germany
  • Cornelius Knabbe; Heart and Diabetes Center NRW, Medical Faculty, Ruhr University Bochum, Institute for Laboratory and Transfusion Medicine, Bochum, Germany
  • Martin Hellmich; Institute of Medical Statistics and Computational Biology, Faculty of Medicine and University Hospital Cologne, University of Cologne
  • Michael Buess; Health department of Cologne, Cologne, Germany
  • Anna Wolf; Health department of Cologne, Cologne, Germany
  • Annelene Kossow; Health department of Cologne, Cologne, Germany
  • Johannes Niessen; Health department of Cologne, Cologne, Germany
  • Sebastian Jeworutzki; Faculty of Social Science, Ruhr-University Bochum, Bochum, Germany
  • Joerg Schraepler; Faculty of Social Science, Ruhr-University Bochum, Bochum, Germany
  • Michael Laessig; Institute for Biological Physics, University of Cologne, Cologne, Germany
  • Joerg Doetsch; Department of Pediatrics, Childrens and Adolescents Hospital, University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany
  • Gerd Faetkenheuer; Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany
  • Rolf Kaiser; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  • Andreas Beyer; CECAD Research center, University of Cologne, Cologne, Germany
  • Jan Rybniker; Department I of Internal Medicine, Division of Infectious Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany
  • Florian Klein; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
Preprint em Inglês | medRxiv | ID: ppmedrxiv-22270304
ABSTRACT
Systematic SARS-CoV-2 testing is a valuable tool for infection control and surveillance. However, broad application of high sensitive RT-qPCR testing in children is often hampered due to unpleasant sample collection, limited RT-qPCR capacities and high costs. Here, we developed a high-throughput approach ( Lolli-Method) for SARS-CoV-2 detection in children, combining non-invasive sample collection with an RT-qPCR-pool testing strategy. SARS-CoV-2 infections were diagnosed with sensitivities of 100% and 93.9% when viral loads were >106 copies/ml and >103 copies/ml in corresponding Naso-/Oropharyngeal-swabs, respectively. For effective application of the Lolli-Method in schools and daycare facilities, SEIR-modeling indicated a preferred frequency of two tests per week. The developed test strategy was implemented in 3,700 schools and 698 daycare facilities in Germany, screening over 800,000 individuals twice per week. In a period of 3 months, 6,364 pool-RT-qPCRs tested positive (0.64%), ranging from 0.05% to 2.61% per week. Notably, infections correlated with local SARS-CoV-2 incidences and with a school social deprivation index. Moreover, in comparison with the alpha variant, statistical modeling revealed a 36.8% increase for multiple ([≥]2 children) infections per class following infections with the delta variant. We conclude that the Lolli-Method is a powerful tool for SARS-CoV-2 surveillance and infection control in schools and daycare.
Licença
cc_by_nc_nd
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo diagnóstico / Experimental_studies / Estudo observacional / Revisão sistemática Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo diagnóstico / Experimental_studies / Estudo observacional / Revisão sistemática Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
...